Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells - Thaler, Sonja; Roßwag, Sven; Sleeman, Jonathan P. (OncoTarget, 2017)
Gesehen am 08.10.2018